Long-Term Outcome of Paediatric Crohn's Disease Patients With Deep Ulcerations at Diagnosis
- PMID: 40332985
- PMCID: PMC12336948
- DOI: 10.1111/apa.70115
Long-Term Outcome of Paediatric Crohn's Disease Patients With Deep Ulcerations at Diagnosis
Abstract
Aim: Presence of deep ulcerations (DU) at diagnosis seems to be predictive of a more severe phenotype in adult Crohn's disease (CD). The aim of our study was to investigate if the presence of DU at diagnosis was associated with a more severe disease course over time in children.
Methods: In this monocentric retrospective study, we analysed data from paediatric patients with a new diagnosis of CD from 2009 to 2017. Clinical, laboratory data, treatments and complications were recorded for each patient at diagnosis and at 1, 3 and 5 years of follow-up. Patients were compared according to the presence or absence of DU on colonoscopy.
Results: Among the 116 patients included in the study, 52 patients had DU at diagnosis. Comparison showed an increased risk for patients with DU to develop abdominal abscesses (p = 0.045) and to experience more relapses (p = 0.013) at 1 year. At 3 and 5 years, there was no longer any difference between groups. The time from diagnosis to first anti-TNF alpha was shorter in DU patients.
Conclusion: The presence of DU at diagnosis is associated with more complications during the first year of follow-up but not after, due to a more active therapeutic management.
Keywords: IBD; children; endoscopy; prognostic factor; ulcerations.
© 2025 The Author(s). Acta Paediatrica published by John Wiley & Sons Ltd on behalf of Foundation Acta Paediatrica.
Conflict of interest statement
F.M.R. has received a consultation fee, research grant or honorarium from Janssen, Pfizer, Abbvie, Takeda, Celgene, Nestlé Health Science and Nestlé Nutrition Institute. B.P. has served as a speaker for Biocodex and Amgen. The other authors declare no conflicts of interest.
Figures
References
-
- Turner D., Ricciuto A., Lewis A., et al., “STRIDE‐II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat‐To‐Target Strategies in IBD,” Gastroenterology 160 (2021): 1570–1583, 10.1053/j.gastro.2020.12.031. - DOI - PubMed
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
